Solid Formulations Drug Delivery Market, Global Outlook and Forecast 2022-2028

June 2022 | 109 pages | ID: S26CC0E16D65EN
Market Monitor Global

Abstracts

Solid Formulations are a solid body drug delivery system of various weights and shapes, adapted for introduction into orifices of the human body.4 The external membrane of the suppository will typically melt, soften, or dissolve at body temperature which allows the active ingredient to then be absorbed by the surrounding tissue. Suppository bases usually employed are cocoa butter, glycerinated gelatin, hydrogenated vegetable oils, mixtures of polyethylene glycols of various molecular weights, and fatty acid esters of polyethylene glycol. The suppository base employed has a marked influence on the release of the active ingredient incorporated in it.

This report contains market size and forecasts of Solid Formulations Drug Delivery in Global, including the following market information:

Global Solid Formulations Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Solid Formulations Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Powders Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Solid Formulations Drug Delivery include Pfizer, Teva Pharmaceuticals, Bristol Myers Squibb, Lead Chemical, Purdue Pharma, Glenmark Pharmaceuticals, Galderma, Johnson & Johnson Private and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Solid Formulations Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Solid Formulations Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Solid Formulations Drug Delivery Market Segment Percentages, by Type, 2021 (%)

• Powders
• Suppositories

Global Solid Formulations Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Solid Formulations Drug Delivery Market Segment Percentages, by Application, 2021 (%)

• Home Care Settings
• Hospitals & Clinics
• Burn Centers
• Other Facilities

Global Solid Formulations Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Solid Formulations Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Solid Formulations Drug Delivery revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Solid Formulations Drug Delivery revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Teva Pharmaceuticals
• Bristol Myers Squibb
• Lead Chemical
• Purdue Pharma
• Glenmark Pharmaceuticals
• Galderma
• Johnson & Johnson Private
• GlaxoSmithKline
• Bausch Health Companies
• Hisamitsu Pharmaceuticals
• Cipla
• Bayer
• Viatris
• 3M
• Merck & Co
• Crescita Therpeautics
• Novartis International
• Boehringer Ingelheim

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Solid Formulations Drug Delivery Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Solid Formulations Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SOLID FORMULATIONS DRUG DELIVERY OVERALL MARKET SIZE

2.1 Global Solid Formulations Drug Delivery Market Size: 2021 VS 2028
2.2 Global Solid Formulations Drug Delivery Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Solid Formulations Drug Delivery Players in Global Market
3.2 Top Global Solid Formulations Drug Delivery Companies Ranked by Revenue
3.3 Global Solid Formulations Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Solid Formulations Drug Delivery Companies in Global Market, by Revenue in 2021
3.5 Global Companies Solid Formulations Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Solid Formulations Drug Delivery Players in Global Market
  3.6.1 List of Global Tier 1 Solid Formulations Drug Delivery Companies
  3.6.2 List of Global Tier 2 and Tier 3 Solid Formulations Drug Delivery Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Solid Formulations Drug Delivery Market Size Markets, 2021 & 2028
  4.1.2 Powders
  4.1.3 Suppositories
4.2 By Type - Global Solid Formulations Drug Delivery Revenue & Forecasts
  4.2.1 By Type - Global Solid Formulations Drug Delivery Revenue, 2017-2022
  4.2.2 By Type - Global Solid Formulations Drug Delivery Revenue, 2023-2028
  4.2.3 By Type - Global Solid Formulations Drug Delivery Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Solid Formulations Drug Delivery Market Size, 2021 & 2028
  5.1.2 Home Care Settings
  5.1.3 Hospitals & Clinics
  5.1.4 Burn Centers
  5.1.5 Other Facilities
5.2 By Application - Global Solid Formulations Drug Delivery Revenue & Forecasts
  5.2.1 By Application - Global Solid Formulations Drug Delivery Revenue, 2017-2022
  5.2.2 By Application - Global Solid Formulations Drug Delivery Revenue, 2023-2028
  5.2.3 By Application - Global Solid Formulations Drug Delivery Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Solid Formulations Drug Delivery Market Size, 2021 & 2028
6.2 By Region - Global Solid Formulations Drug Delivery Revenue & Forecasts
  6.2.1 By Region - Global Solid Formulations Drug Delivery Revenue, 2017-2022
  6.2.2 By Region - Global Solid Formulations Drug Delivery Revenue, 2023-2028
  6.2.3 By Region - Global Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Solid Formulations Drug Delivery Revenue, 2017-2028
  6.3.2 US Solid Formulations Drug Delivery Market Size, 2017-2028
  6.3.3 Canada Solid Formulations Drug Delivery Market Size, 2017-2028
  6.3.4 Mexico Solid Formulations Drug Delivery Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Solid Formulations Drug Delivery Revenue, 2017-2028
  6.4.2 Germany Solid Formulations Drug Delivery Market Size, 2017-2028
  6.4.3 France Solid Formulations Drug Delivery Market Size, 2017-2028
  6.4.4 U.K. Solid Formulations Drug Delivery Market Size, 2017-2028
  6.4.5 Italy Solid Formulations Drug Delivery Market Size, 2017-2028
  6.4.6 Russia Solid Formulations Drug Delivery Market Size, 2017-2028
  6.4.7 Nordic Countries Solid Formulations Drug Delivery Market Size, 2017-2028
  6.4.8 Benelux Solid Formulations Drug Delivery Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Solid Formulations Drug Delivery Revenue, 2017-2028
  6.5.2 China Solid Formulations Drug Delivery Market Size, 2017-2028
  6.5.3 Japan Solid Formulations Drug Delivery Market Size, 2017-2028
  6.5.4 South Korea Solid Formulations Drug Delivery Market Size, 2017-2028
  6.5.5 Southeast Asia Solid Formulations Drug Delivery Market Size, 2017-2028
  6.5.6 India Solid Formulations Drug Delivery Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Solid Formulations Drug Delivery Revenue, 2017-2028
  6.6.2 Brazil Solid Formulations Drug Delivery Market Size, 2017-2028
  6.6.3 Argentina Solid Formulations Drug Delivery Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Solid Formulations Drug Delivery Revenue, 2017-2028
  6.7.2 Turkey Solid Formulations Drug Delivery Market Size, 2017-2028
  6.7.3 Israel Solid Formulations Drug Delivery Market Size, 2017-2028
  6.7.4 Saudi Arabia Solid Formulations Drug Delivery Market Size, 2017-2028
  6.7.5 UAE Solid Formulations Drug Delivery Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Solid Formulations Drug Delivery Major Product Offerings
  7.1.4 Pfizer Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Teva Pharmaceuticals
  7.2.1 Teva Pharmaceuticals Corporate Summary
  7.2.2 Teva Pharmaceuticals Business Overview
  7.2.3 Teva Pharmaceuticals Solid Formulations Drug Delivery Major Product Offerings
  7.2.4 Teva Pharmaceuticals Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.2.5 Teva Pharmaceuticals Key News
7.3 Bristol Myers Squibb
  7.3.1 Bristol Myers Squibb Corporate Summary
  7.3.2 Bristol Myers Squibb Business Overview
  7.3.3 Bristol Myers Squibb Solid Formulations Drug Delivery Major Product Offerings
  7.3.4 Bristol Myers Squibb Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.3.5 Bristol Myers Squibb Key News
7.4 Lead Chemical
  7.4.1 Lead Chemical Corporate Summary
  7.4.2 Lead Chemical Business Overview
  7.4.3 Lead Chemical Solid Formulations Drug Delivery Major Product Offerings
  7.4.4 Lead Chemical Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.4.5 Lead Chemical Key News
7.5 Purdue Pharma
  7.5.1 Purdue Pharma Corporate Summary
  7.5.2 Purdue Pharma Business Overview
  7.5.3 Purdue Pharma Solid Formulations Drug Delivery Major Product Offerings
  7.5.4 Purdue Pharma Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.5.5 Purdue Pharma Key News
7.6 Glenmark Pharmaceuticals
  7.6.1 Glenmark Pharmaceuticals Corporate Summary
  7.6.2 Glenmark Pharmaceuticals Business Overview
  7.6.3 Glenmark Pharmaceuticals Solid Formulations Drug Delivery Major Product Offerings
  7.6.4 Glenmark Pharmaceuticals Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.6.5 Glenmark Pharmaceuticals Key News
7.7 Galderma
  7.7.1 Galderma Corporate Summary
  7.7.2 Galderma Business Overview
  7.7.3 Galderma Solid Formulations Drug Delivery Major Product Offerings
  7.7.4 Galderma Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.7.5 Galderma Key News
7.8 Johnson & Johnson Private
  7.8.1 Johnson & Johnson Private Corporate Summary
  7.8.2 Johnson & Johnson Private Business Overview
  7.8.3 Johnson & Johnson Private Solid Formulations Drug Delivery Major Product Offerings
  7.8.4 Johnson & Johnson Private Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.8.5 Johnson & Johnson Private Key News
7.9 GlaxoSmithKline
  7.9.1 GlaxoSmithKline Corporate Summary
  7.9.2 GlaxoSmithKline Business Overview
  7.9.3 GlaxoSmithKline Solid Formulations Drug Delivery Major Product Offerings
  7.9.4 GlaxoSmithKline Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.9.5 GlaxoSmithKline Key News
7.10 Bausch Health Companies
  7.10.1 Bausch Health Companies Corporate Summary
  7.10.2 Bausch Health Companies Business Overview
  7.10.3 Bausch Health Companies Solid Formulations Drug Delivery Major Product Offerings
  7.10.4 Bausch Health Companies Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.10.5 Bausch Health Companies Key News
7.11 Hisamitsu Pharmaceuticals
  7.11.1 Hisamitsu Pharmaceuticals Corporate Summary
  7.11.2 Hisamitsu Pharmaceuticals Business Overview
  7.11.3 Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Major Product Offerings
  7.11.4 Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.11.5 Hisamitsu Pharmaceuticals Key News
7.12 Cipla
  7.12.1 Cipla Corporate Summary
  7.12.2 Cipla Business Overview
  7.12.3 Cipla Solid Formulations Drug Delivery Major Product Offerings
  7.12.4 Cipla Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.12.5 Cipla Key News
7.13 Bayer
  7.13.1 Bayer Corporate Summary
  7.13.2 Bayer Business Overview
  7.13.3 Bayer Solid Formulations Drug Delivery Major Product Offerings
  7.13.4 Bayer Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.13.5 Bayer Key News
7.14 Viatris
  7.14.1 Viatris Corporate Summary
  7.14.2 Viatris Business Overview
  7.14.3 Viatris Solid Formulations Drug Delivery Major Product Offerings
  7.14.4 Viatris Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.14.5 Viatris Key News
7.15 3M
  7.15.1 3M Corporate Summary
  7.15.2 3M Business Overview
  7.15.3 3M Solid Formulations Drug Delivery Major Product Offerings
  7.15.4 3M Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.15.5 3M Key News
7.16 Merck & Co
  7.16.1 Merck & Co Corporate Summary
  7.16.2 Merck & Co Business Overview
  7.16.3 Merck & Co Solid Formulations Drug Delivery Major Product Offerings
  7.16.4 Merck & Co Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.16.5 Merck & Co Key News
7.17 Crescita Therpeautics
  7.17.1 Crescita Therpeautics Corporate Summary
  7.17.2 Crescita Therpeautics Business Overview
  7.17.3 Crescita Therpeautics Solid Formulations Drug Delivery Major Product Offerings
  7.17.4 Crescita Therpeautics Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.17.5 Crescita Therpeautics Key News
7.18 Novartis International
  7.18.1 Novartis International Corporate Summary
  7.18.2 Novartis International Business Overview
  7.18.3 Novartis International Solid Formulations Drug Delivery Major Product Offerings
  7.18.4 Novartis International Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.18.5 Novartis International Key News
7.19 Boehringer Ingelheim
  7.19.1 Boehringer Ingelheim Corporate Summary
  7.19.2 Boehringer Ingelheim Business Overview
  7.19.3 Boehringer Ingelheim Solid Formulations Drug Delivery Major Product Offerings
  7.19.4 Boehringer Ingelheim Solid Formulations Drug Delivery Revenue in Global Market (2017-2022)
  7.19.5 Boehringer Ingelheim Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Solid Formulations Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Solid Formulations Drug Delivery Market Drivers in Global Market
Table 3. Solid Formulations Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Solid Formulations Drug Delivery in Global Market
Table 5. Top Solid Formulations Drug Delivery Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Solid Formulations Drug Delivery Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Solid Formulations Drug Delivery Revenue Share by Companies, 2017-2022
Table 8. Global Companies Solid Formulations Drug Delivery Product Type
Table 9. List of Global Tier 1 Solid Formulations Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Solid Formulations Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Solid Formulations Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Solid Formulations Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Solid Formulations Drug Delivery Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Solid Formulations Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Solid Formulations Drug Delivery Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Solid Formulations Drug Delivery Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Solid Formulations Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Solid Formulations Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Solid Formulations Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Solid Formulations Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Solid Formulations Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Solid Formulations Drug Delivery Product Offerings
Table 32. Pfizer Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 33. Teva Pharmaceuticals Corporate Summary
Table 34. Teva Pharmaceuticals Solid Formulations Drug Delivery Product Offerings
Table 35. Teva Pharmaceuticals Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 36. Bristol Myers Squibb Corporate Summary
Table 37. Bristol Myers Squibb Solid Formulations Drug Delivery Product Offerings
Table 38. Bristol Myers Squibb Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 39. Lead Chemical Corporate Summary
Table 40. Lead Chemical Solid Formulations Drug Delivery Product Offerings
Table 41. Lead Chemical Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 42. Purdue Pharma Corporate Summary
Table 43. Purdue Pharma Solid Formulations Drug Delivery Product Offerings
Table 44. Purdue Pharma Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 45. Glenmark Pharmaceuticals Corporate Summary
Table 46. Glenmark Pharmaceuticals Solid Formulations Drug Delivery Product Offerings
Table 47. Glenmark Pharmaceuticals Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 48. Galderma Corporate Summary
Table 49. Galderma Solid Formulations Drug Delivery Product Offerings
Table 50. Galderma Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 51. Johnson & Johnson Private Corporate Summary
Table 52. Johnson & Johnson Private Solid Formulations Drug Delivery Product Offerings
Table 53. Johnson & Johnson Private Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 54. GlaxoSmithKline Corporate Summary
Table 55. GlaxoSmithKline Solid Formulations Drug Delivery Product Offerings
Table 56. GlaxoSmithKline Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 57. Bausch Health Companies Corporate Summary
Table 58. Bausch Health Companies Solid Formulations Drug Delivery Product Offerings
Table 59. Bausch Health Companies Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 60. Hisamitsu Pharmaceuticals Corporate Summary
Table 61. Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Product Offerings
Table 62. Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 63. Cipla Corporate Summary
Table 64. Cipla Solid Formulations Drug Delivery Product Offerings
Table 65. Cipla Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 66. Bayer Corporate Summary
Table 67. Bayer Solid Formulations Drug Delivery Product Offerings
Table 68. Bayer Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 69. Viatris Corporate Summary
Table 70. Viatris Solid Formulations Drug Delivery Product Offerings
Table 71. Viatris Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 72. 3M Corporate Summary
Table 73. 3M Solid Formulations Drug Delivery Product Offerings
Table 74. 3M Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 75. Merck & Co Corporate Summary
Table 76. Merck & Co Solid Formulations Drug Delivery Product Offerings
Table 77. Merck & Co Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 78. Crescita Therpeautics Corporate Summary
Table 79. Crescita Therpeautics Solid Formulations Drug Delivery Product Offerings
Table 80. Crescita Therpeautics Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 81. Novartis International Corporate Summary
Table 82. Novartis International Solid Formulations Drug Delivery Product Offerings
Table 83. Novartis International Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)
Table 84. Boehringer Ingelheim Corporate Summary
Table 85. Boehringer Ingelheim Solid Formulations Drug Delivery Product Offerings
Table 86. Boehringer Ingelheim Solid Formulations Drug Delivery Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Solid Formulations Drug Delivery Segment by Type in 2021
Figure 2. Solid Formulations Drug Delivery Segment by Application in 2021
Figure 3. Global Solid Formulations Drug Delivery Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Solid Formulations Drug Delivery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Solid Formulations Drug Delivery Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Solid Formulations Drug Delivery Revenue in 2021
Figure 8. By Type - Global Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 9. By Application - Global Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 10. By Region - Global Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 11. By Country - North America Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 12. US Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 16. Germany Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 17. France Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 24. China Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 28. India Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 30. Brazil Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Solid Formulations Drug Delivery Revenue Market Share, 2017-2028
Figure 33. Turkey Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Solid Formulations Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Pharmaceuticals Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol Myers Squibb Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Lead Chemical Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Purdue Pharma Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Glenmark Pharmaceuticals Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Galderma Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Johnson & Johnson Private Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GlaxoSmithKline Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Bausch Health Companies Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Hisamitsu Pharmaceuticals Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Cipla Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Bayer Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Viatris Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. 3M Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Merck & Co Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Crescita Therpeautics Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Novartis International Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Boehringer Ingelheim Solid Formulations Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2017-2022)